About the Authors

Sophie Githinji, Robert W. Snow, Dejan Zurovac
Malaria Public Health Cluster, KEMRI-Wellcome Trust–University of Oxford Collaborative Programme, Nairobi, Kenya

Samwel Kigen, Dorothy Memusi, Andrew Nyandigisi, Agneta M. Mbithi, Andrew Wamari
Division of Malaria Control, Ministry of Public Health & Sanitation, Nairobi, Kenya

Alex N. Muturi
Management for Sciences of Health, Nairobi, Kenya

George Jagoe
Medicines for Malaria Venture, Geneva, Switzerland

Jim Barrington
SMS for Life, Novartis AG, Basel, Switzerland

Robert W. Snow, Dejan Zurovac
Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

Dejan Zurovac
Center for Global Health and Development, Boston University School of Public Health, Boston, Massachusetts, United States of America

Corresponding Author

sgithinji@nairobi.kemri-wellcome.org

Competing Interests

The authors have read the journal's policy and have the following conflicts: the authors confirm that commercial source (Novartis Pharma AG), funded part of the project. They also confirm that JB is an employee of Novartis Pharma AG and that DZ and RWS have received a fee for speaking at a meeting organized by Novartis Pharma AG. Finally, the authors also state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: SG SK DM AN AMM AW ANM JB GJ DZ. Performed the experiments: SG SK DM AN AMM AW ANM JB DZ. Analyzed the data: SG DZ. Contributed reagents/materials/analysis tools: SG DZ. Wrote the paper: SG SK DM AN AMM AW ANM GJ JB RWS DZ.